Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Condition: Clear Cell Renal Cell Carcinoma Intervention: Drug: ARO-HIF2 Sponsor: Arrowhead Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials